Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$322M |
| 2 |
UnitedHealth
UNH
|
+$233M |
| 3 |
Microsoft
MSFT
|
+$198M |
| 4 |
International Flavors & Fragrances
IFF
|
+$171M |
| 5 |
Principal Financial Group
PFG
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$714M |
| 2 |
IBM
IBM
|
+$395M |
| 3 |
Cisco
CSCO
|
+$303M |
| 4 |
Procter & Gamble
PG
|
+$290M |
| 5 |
Macy's
M
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.98% |
| 2 | Financials | 14.9% |
| 3 | Healthcare | 12.91% |
| 4 | Industrials | 10.1% |
| 5 | Consumer Discretionary | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLUE
1826
DELISTED
bluebird bio
BLUE
| $12.8M | ﹤0.01% |
15,954
+902
| +6% | +$716K |
|
|
GNC
1827
DELISTED
GNC Holdings, Inc.
GNC
| $12.7M | ﹤0.01% |
1,154,809
+484,657
| +72% | +$7.58M |
|
1828
Vanguard Morningstar Mega Cap ETF
MGC
$10.4B
| $12.7M | ﹤0.01% |
166,295
+4,282
| +3% | +$319K |
|
1829
Park National Corp
PRK
$3.75B
| $12.6M | ﹤0.01% |
105,681
+15,814
| +18% | +$1.69M |
|
1830
Anika Therapeutics
ANIK
$288M
| $12.6M | ﹤0.01% |
257,921
+53,922
| +26% | +$2.49M |
|
|
ECHO
1831
EchoStar
ECHO
$26.7B
| $12.6M | ﹤0.01% |
302,852
+57,897
| +24% | +$2.3M |
|
|
MNR
1832
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $12.6M | ﹤0.01% |
826,662
+3,585
| +0.4% | +$49.5K |
|
|
SUP
1833
DELISTED
Superior Industries International
SUP
| $12.6M | ﹤0.01% |
477,994
-19,481
| -4% | -$514K |
|
|
LABL
1834
DELISTED
Multi-Color Corp
LABL
| $12.5M | ﹤0.01% |
161,624
+11,292
| +8% | +$799K |
|
1835
Capitol Federal Financial
CFFN
$1.08B
| $12.5M | ﹤0.01% |
761,556
+89,056
| +13% | +$1.37M |
|
1836
Guidewire Software
GWRE
$14.6B
| $12.5M | ﹤0.01% |
253,971
+14,320
| +6% | +$803K |
|
1837
Quad
QUAD
$513M
| $12.5M | ﹤0.01% |
465,313
-220,356
| -32% | -$5.7M |
|
|
ARIA
1838
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $12.5M | ﹤0.01% |
1,005,186
-20,179
| -2% | -$243K |
|
|
SFLY
1839
DELISTED
Shutterfly, Inc.
SFLY
| $12.5M | ﹤0.01% |
248,872
+33,647
| +16% | +$1.63M |
|
|
CS
1840
DELISTED
Credit Suisse Group
CS
| $12.5M | ﹤0.01% |
872,634
+172,082
| +25% | +$2.41M |
|
|
WMGI
1841
DELISTED
Wright Medical Group Inc
WMGI
| $12.3M | ﹤0.01% |
537,390
+74,436
| +16% | +$1.73M |
|
1842
SPX Corp
SPXC
$10.9B
| $12.3M | ﹤0.01% |
520,167
+52,067
| +11% | +$1.14M |
|
1843
Enovis
ENOV
$1.5B
| $12.3M | ﹤0.01% |
199,490
+5,005
| +3% | +$296K |
|
1844
Ultragenyx Pharmaceutical
RARE
$2.61B
| $12.3M | ﹤0.01% |
175,062
+10,186
| +6% | +$723K |
|
|
MORE
1845
DELISTED
Monogram Residential Trust, Inc.
MORE
| $12.3M | ﹤0.01% |
1,136,529
+78,922
| +7% | +$831K |
|
1846
Sanofi
SNY
$105B
| $12.2M | ﹤0.01% |
302,313
-18,022
| -6% | -$710K |
|
|
HIBB
1847
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $12.2M | ﹤0.01% |
327,704
+4,036
| +1% | +$163K |
|
|
CSFL
1848
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $12.2M | ﹤0.01% |
485,341
+25,642
| +6% | +$545K |
|
|
UBA
1849
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $12.2M | ﹤0.01% |
504,778
+49,119
| +11% | +$1.09M |
|
|
FOE
1850
DELISTED
Ferro Corporation
FOE
| $12.2M | ﹤0.01% |
848,753
+262,539
| +45% | +$3.73M |
|
Similar funds
Bank of New York Mellon's Q4 2016 Portfolio in Review
As of Q4 2016, Bank of New York Mellon held 4,430 positions worth $347B, up 3.3% from $336B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bank of New York Mellon's Q4 2016 filing shows 161 new, 2,590 increased, 1,402 reduced and 170 closed positions. Its largest new stake was Lamb Weston: 2,449,932 shares worth $92.7M. The largest sale was Merck, an estimated $714M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q4 2016 buy was Lamb Weston: 2,449,932 shares worth $92.7M.
- Bank of New York Mellon added most to CME Group in Q4 2016, an estimated $322M increase.
- Bank of New York Mellon's biggest Q4 2016 reduction was Merck, cutting an estimated $714M.
- Bank of New York Mellon fully exited LinkedIn Corporation in Q4 2016, selling an estimated $82.8M.
- Bank of New York Mellon's ten largest holdings make up 13% of its $347B portfolio in Q4 2016.
- Bank of New York Mellon opened 161 new positions and closed 170 in Q4 2016.
- Bank of New York Mellon's portfolio value rose 3.3% quarter-over-quarter to $347B.
Based on Bank of New York Mellon's 13F filing for Q4 2016, filed 13 Feb 2017.